PeƱonal, Ryner John .
HRN: 22-06-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/13/2024
09/20/2024
IV DRIP
1.3g
Q8
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes